Skip to main content

Table 1 Descriptive statistics of the cohort stratified by secretor status and overall given as median [Q1; Q3] for HMO and mean (standard deviation) for the other continuous variables. Group differences were tested using Kruskal-Wallis-tests (HMO) and t-tests (other variables)

From: Concentrations of oligosaccharides in human milk and child growth

 

Secretor (n = 124)

Non-secretor (n = 21)

p-value

Total

n = 145

n (non-missing)

Maternal age (years)

30.3 (4.12)

30.2 (4.95)

0.898

30.3 (4.24)

143

Pre-pregnancy BMI (kg/m2)

23.2 (3.78)

22.7 (3.83)

0.642

23.2 (3.78)

124

Gestational age (months)

40.0 (1.15)

40.2 (1.26)

0.494

40.0 (1.16)

145

Birth weight (g)

3467 (473)

3646 (486)

0.13

3493 (477)

145

Birth length (cm)

50.3 (2.37)

50.7 (2.28)

0.475

50.4 (2.36)

144

Birth head circumference (cm)

34.9 (1.51)

35.3 (1.33)

0.301

35.0 (1.48)

123

HMO (mg/L)

 2‘FL

2038 [1536;2722]

7.37 [6.66;10.0]

< 0.001

1931 [1317;2414]

145

 3-FL

785 [531;1114]

2544 [2007;2889]

< 0.001

916 [565;1227]

145

 3′SL

136 [119;162]

160 [134;173]

0.026

138 [120;166]

145

 6′SL

151 [104;201]

139 [111;265]

0.39

150 [104;207]

145

 LNT

547 [353;720]

699 [545;934]

0.01

567 [361;764]

145

 LNnT

149 [117;200]

66.9 [38.8;89.9]

< 0.001

137 [90.8;185]

145

 LNFP-I

473 [292;839]

2.00 [2.00;2.00]

< 0.001

416 [196;789]

145

 LNFP-V

44.6 [31.3;61.9]

197 [141;235]

< 0.001

50.1 [33.7;83.5]

145

 LNnFP

16.6 [9.51;22.7]

17.6 [7.56;21.6]

0.848

16.7 [8.82;22.7]

145

  1. BMI Body Mass Index, HMO Human Milk Oligosaccharide, 2’FL 2′-fucosyllactose, 3-FL 3-fucosyllactose, 3′SL 3′-sialyllactose, 6′SL 6′-sialyllactose, LNT lacto-N-tetraose, LNnT lacto-N-neotetraose, LNFP-I lacto-N-fucopentaose-I, LNFP-V lacto-N-fucopentaose-V, LNnFP lacto-N-neofucopentaose